XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ: XTLB · IEX Real-Time Price · USD
2.810
+0.110 (4.07%)
At close: Mar 28, 2024, 4:00 PM
2.720
-0.090 (-3.20%)
After-hours: Mar 28, 2024, 7:47 PM EDT

XTL Biopharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019201820172016201520142013 2012 - 2003
Net Income
-1.350.44-2.95-0.763.63-0.78-2.55-4.31-2.53-2.48
Upgrade
Other Operating Activities
0.45-1.482.1-0.15-4.45-0.340.812.450.06-0.02
Upgrade
Operating Cash Flow
-0.9-1.05-0.85-0.91-0.82-1.13-1.73-1.86-2.47-2.5
Upgrade
Capital Expenditures
00-0-000-0-0-0.01-0.08
Upgrade
Acquisitions
0000000-0.060.293.05
Upgrade
Change in Investments
0.040.010.032.110.78-2.500.011.220.37
Upgrade
Other Investing Activities
-------0.06-0.06-0-
Upgrade
Investing Cash Flow
0.040.010.032.110.78-2.5-0.07-0.111.53.34
Upgrade
Share Issuance / Repurchase
000004.8903.560.310.32
Upgrade
Other Financing Activities
-0.39-----0.02--
Upgrade
Financing Cash Flow
00.390004.8903.580.310.32
Upgrade
Exchange Rate Effect
-0.01-0.01-0.01-00-00-0-0.010.04
Upgrade
Net Cash Flow
-0.87-0.66-0.821.2-0.041.27-1.81.61-0.661.15
Upgrade
Free Cash Flow
-0.9-1.05-0.85-0.91-0.82-1.12-1.73-1.86-2.48-2.58
Upgrade
Free Cash Flow Per Share
-0.17-0.20-0.17-0.18-0.16-0.24-0.63-0.71-1.07-5.78
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).